As shown in Fig 1A, CCK-8 assay was employed to investigate the effect of MSM and EGFR-TKI on the viability of chicken IECs. According to the results of the CCK-8 assay, it was shown that at 24 h after transfection, no significant difference was found in cell viability among the LPS+MSM, LPS+TKI and LPS+TKI+MSM groups (P>0.05).
Similar study has found that in fetal horse liver cells, MSM reduced ROS generation without affecting cell viability
(Kim et al., 2020b). The latest research showed that within the range of 0-200 mM MSM concentration, there was no notable difference between 6 and 12 h (P>0.01). But the higher the MSM concentration, the survival rate of chicken macrophages (HD11 cells) more obviously decreased (P<0.01) in a time-dependent manner
(Miao et al., 2022). According to the results (Fig 1B), the EdU incorporation assay revealed that LPS+MSM group (38.81%) could markedly promote cell proliferation in chicken IECs (P<0.05) compared with the LPS+TKI group.
Shah et al., (2019) modelled acquired resistance in EGFR-mutant lung adenocarcinoma cells and found that AKIs synergistically inhibited cancer cell growth in combination with EGFR inhibitors in mouse and patient-derived xenograft models. Meanwhile,
Gong et al., (2020) found that a combination of erlotinib plus anifrolumab resulted in significant (P<0.05) suppression of tumor growth. These results indicated that MSM could promote the proliferation of chicken IECs at an appropriate concentration, while inhibition of EGFR affects the recovery of proliferation in chicken IECs induced by LPS.
We next investigated the cell cycle in chicken IECs by using a flow cytometry analysis. The current results showed that in the LPS+TKI group the percentage of chicken IECs in G0/G1 phase increased significantly (P<0.01), while S phase decreased significantly (P<0.01), indicating that EGFR-TKI can block the synthesis of essential proteins in cell cycle from G1 to S phase, leading to cell cycle arrest and apoptosis (Fig 2).
Meanwhile, the percentage of chicken IECs in G2/M phase decreased significantly (P<0.05) in LPS+TKI+MSM group compared with the LPS+TKI and LPS+MSM groups, indicating that the combination of MSM and EGFR-TKI can block the cell cycle arrest from S phase to G2/M phase (Fig 2). These results were similar to most experimental results, research on EGFR-TKI showed that the anti-EGFR monoclonal antibody C225 had effects on cell proliferation, cell cycle phase distribution and apoptosis in squamous cell carcinoma (SCC) cell lines. C225 could have inhibited SCC proliferation and induced accumulation of cells in G1, which is accompanied by a 2-3-fold decrease in the percentage of cells in S phase
(Huang et al., 1999). Kersting et al., (2018) also found that the inhibition of EGFR causes cell cycle arrest in G1 prior to DNA synthesis.
Ling et al., (2018) demonstrated that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4. Meanwhile, previous study also indicates that MSM can induces cell cycle,
Sarkhani et al., (2017) found that the combination treatment (MSM+allicin) inhibited CD4
- and CD44
+ cells in the G2/M and S phases of the cell cycle, respectively. In addition, MSM supplementation to human gastric, hepatocellular and esophageal carcinoma cell cultures did elicit cytotoxic effects by arresting the G2/M phase of the cell
(Jafari et al., 2012). Therefore, according to the results of the current study, we found that both EGFR-TKI and MSM have effect on the proliferation and cell cycle of chicken IECs and the addition of MSM can promote the recovery of cell proliferation and cell cycle of S phase when EGFR inhibited. However, at present, the research on EGFR is mostly focused on human cancer and tumor cells, the relationship between EGFR and other signal pathways, the mechanism of interaction regulation,
etc. are not yet totally clear. At the same time, there are few reports on the mechanism of EGFR in the regulation of anti-inflammatory drugs and MSM, as an anti-inflammatory drug, has a complex mechanism in regulating cell proliferation and apoptosis of various tumors and cancer cells. Furthermore, different cell types and different concentrations of MSM had different effects on cell proliferation and cell cycle arrest, more studies are needed to further explore.
As shown in Fig 3, ELISA assay was used to measure the concentrations of TNF-α, IL-1β and IL-6 in the chicken IECs.
The levels of TNF-α, IL-1β and IL-6 in the LPS group were significantly higher than those in the other groups (P<0.01); and the levels of IL-1β and IL-6 in the LPS+TKI group were significantly lower than those in the LPS+TKI+MSM groups (P<0.01), these results indicating that both MSM and EGFR-TKI had an anti-inflammatory effect on chicken IECs induced by LPS. EGFR inhibitors are well-known as anticancer agents, recent studies tried to develop EGFR inhibitors as anti-inflammatory agents.
Elkamhawy et al., (2019) proved that compound 4d (EGFR inhibitor) significantly and dose-dependently inhibits LPS-induced iNOS expression and IL-1β, IL-6 and TNF-β production
via NF-κB inactivation in peritoneal macrophages. TNF-β, IL-1β and IL-6 are important inflammatory mediators, a number of
in vitro studies suggest that MSM exerts an anti-inflammatory effect through the reduction in cytokine expression
(Butawan et al., 2017). The main finding of previous studies was that the inhibitory effect of NF-κB results in the down regulation of mRNA for IL-1β, IL-6 and TNF-α
in vitro. The latest study have shown that 500 mM MSM has a mitigating effect on mycoplasma (MG)-induced inflammatory damage in chicken and chicken HD11 cells and MSM can strongly inhibit IL-6, IL-1β and TNF-α mRNA expression by reducing phosphorylation of the ERK/JNK-MAPK pathway
(Miao et al., 2022). ERK/JNK-MAPK is a classical downstream signal pathway of EGFR. Meanwhile, in the current study, we noticed that both EGFR-TKI and MSM had anti-inflammatory effect, the concentrations of TNF-α, IL-1β and IL-6 in LPS+TKI+MSM group had no significant difference compared with LPS +MSM group, indicating that when the expression of EGFR is inhibited, the anti-inflammatory effect of MSM is not weakened, which may be due to a variety of reasons, such as the dose of MSM added, the anti-inflammatory effect of EGFR-TKI mentioned earlier and the extremely complex regulation mechanism of EGFR signaling pathway. As shown in Fig 4, we preliminarily explored the regulation of MSM on the dynamic expression of EGFR.
The results have shown that MSM could significantly up-regulate the mRNA expression of EGFR and the p-EGFR protein expression in LPS-induced chicken IECs (P<0.01), this also might be the reason that when the expression of EGFR is inhibited, the anti-inflammatory effect of MSM is not weakened. These results concluded that EGFR-TKI, MSM and EGFR-TKI plus MSM played a significant anti-inflammatory role in chicken IECs induced by LPS, this seems to provide new ideas for our follow-up research to explore a new ways of supplementation MSM in poultry.